CN112725294B - Aflatoxin degrading enzyme mutant and high-yield strain thereof - Google Patents

Aflatoxin degrading enzyme mutant and high-yield strain thereof Download PDF

Info

Publication number
CN112725294B
CN112725294B CN202110124615.5A CN202110124615A CN112725294B CN 112725294 B CN112725294 B CN 112725294B CN 202110124615 A CN202110124615 A CN 202110124615A CN 112725294 B CN112725294 B CN 112725294B
Authority
CN
China
Prior art keywords
aflatoxin
leu
asp
enzyme
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110124615.5A
Other languages
Chinese (zh)
Other versions
CN112725294A (en
Inventor
程斯达
康丽华
李宾
张静静
郭瑞
黄亦钧
李玉强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Weifang Kdn Biotech Co ltd
Qingdao Vland Biotech Group Co Ltd
Original Assignee
Weifang Kdn Biotech Co ltd
Qingdao Vland Biotech Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weifang Kdn Biotech Co ltd, Qingdao Vland Biotech Group Co Ltd filed Critical Weifang Kdn Biotech Co ltd
Priority to CN202110124615.5A priority Critical patent/CN112725294B/en
Publication of CN112725294A publication Critical patent/CN112725294A/en
Application granted granted Critical
Publication of CN112725294B publication Critical patent/CN112725294B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to the technical field of genetic engineering, and particularly provides an aflatoxin degradation enzyme mutant and a production strain of the aflatoxin degradation enzyme. Compared with the wild type, the specific enzyme activity of the mutant is respectively improved by 97.2 percent and 108.5 percent, and the effect is obvious. The pichia pastoris strain provided by the invention can be widely applied to the production of aflatoxin degradation enzyme, and is beneficial to reducing the production cost of the enzyme, thereby promoting the wide application of the pichia pastoris strain in the field of feeds.

Description

Aflatoxin degrading enzyme mutant and high-yield strain thereof
Technical Field
The invention belongs to the technical field of genetic engineering and microbial modification, and particularly relates to an aflatoxin degradation enzyme mutant and a high-yield strain thereof.
Background
Mycotoxins (mycotoxins) are toxic secondary metabolites produced by mold during growth, and mainly include Aflatoxins (AF), trichothecenes (trichothecenes, such as T-2 toxin, neosolanum solani-cenol NEO and vomitoxin DON), zearalenone (zenaloenone, ZEN), ochratoxin a (OTA), and fumonisins (fumonisins). The raw materials such as grains and the like are polluted by the mould in the field, if the environmental temperature and the humidity are proper in the processes of transportation, processing and storage, the mould can continue to grow, and the toxin content can be increased successively. According to the estimation of the Food and Agriculture Organization (FAO) of the United nations, 25% of grains are polluted by mycotoxin every year all over the world, and 2% of grains cannot be eaten on average; in addition, the diseases and death caused by animal poisoning due to toxin pollution cause huge economic loss to the food industry and the animal husbandry.
Among mycotoxins, aflatoxin is the most toxic one, and has the effects of suppressing immunity, inducing mutation, and carcinogenesis. The aflatoxin is a secondary metabolite mainly produced by a plurality of fungi such as aspergillus flavus, aspergillus parasiticus and the like, contains a plurality of derivatives, and is separated and identified at present 1 (AFB 1 ) Aflatoxin B 2 (AFB 2 ) Aflatoxin G 1 (AFG 1 ) Aflatoxin G 2 (AFG 2 ) Aflatoxins M 1 (AFM 1 ) Aflatoxin M 2 (AFM 2 ) Aflatoxins P 1 (AFP 1 ) Aflatoxins Q 1 (AFQ 1 ) Aflatoxin H 1 (AFH 1 ) Aflatoxins GM (AFGM), aflatoxins B 2a (AFB 2a ) And toxol, and the like.
With the knowledge of the hazard of aflatoxin, people hope to effectively eliminate the adverse effect of aflatoxin. At present, physical methods, chemical methods and biological methods are the main methods for eliminating aflatoxin pollution. The physical method for removing aflatoxin mainly comprises the following steps: adsorption, heating, radiation and extraction. The main principle of removing the toxicity of aflatoxin by a chemical method is to utilize a chemical reagent to destroy the toxic structure of aflatoxin, and the chemical methods reported include alkaline electrolyte, ozone, electrolytic sodium chloride, citric acid and the like. The biological degradation of aflatoxin mainly means that metabolites produced by microorganisms destroy the toxic structure of aflatoxin, and the produced degradation products are low-toxic or non-toxic. And such biodegradation is generally considered to be an enzymatic action. Microorganisms having such an action function are mainly classified into two types: fungi and bacteria.
For example, Doyle et al found that Aspergillus parasiticus (Aspergillus parasiticus) is capable of producing lactoperoxidase to degrade aflatoxins. Shantha et al extracted a thermostable enzyme from Phoma spThe enzyme can degrade 99% of AFB 1 . Zjatic et al studied the biodegradation of aflatoxins by white rot fungi (Trametes versicolor). Extraction of 80% aflatoxin B in bioactive substance degradable sample from Armillaria tabescens (Armillaria tabescens) 1 The active substance is then proved to be an intracellular enzyme. 4 strains of strain selected by Teniola et al had degraded AFB 1 Acting bacteria and it is proved that the cause of aflatoxin degradation is enzymatic action. Sunpenium and the like are screened from peanut soil and peanut meal to Bacillus megaterium (Bacillus megaterium), and fermentation supernatant of the Bacillus megaterium can degrade 78.55% of aflatoxin in a sample.
By combining the methods, the physical method and the chemical method damage the quality and the nutrient content of the product to different degrees, and byproducts and treatment agent residues are easy to generate, thereby causing harm to people and animals. Compared with a physical method and a chemical method, the biological method mainly utilizes the metabolism of microorganisms to produce enzyme to degrade aflatoxin. The enzyme method has the advantages of mild treatment conditions, high product quality, strong specificity and the like. Therefore, the enzymatic degradation of aflatoxin is a hot spot of current research.
Disclosure of Invention
The invention aims to provide an aflatoxin degradation enzyme mutant and a production strain of the aflatoxin degradation enzyme. The specific enzyme activity of the mutant is obviously improved, the production cost of the mutant is favorably reduced, and the popularization and the application of the mutant in the field of feed are promoted.
The invention provides an aflatoxin degradation enzyme, the amino acid sequence of which is SEQ ID NO. 1.
One coding nucleotide sequence of the aflatoxin degrading enzyme is SEQ ID NO. 2.
The invention provides an aflatoxin degradation enzyme mutant, which is characterized in that the 93 th amino acid of the aflatoxin degradation enzyme with an amino acid sequence of SEQ ID NO. 1 is changed from Arg to Val.
The amino acid sequence of the mutant is SEQ ID NO. 3, and one coding nucleotide sequence of the mutant is SEQ ID NO. 4.
The invention also provides an aflatoxin degradation enzyme mutant, which has the amino acid sequence of SEQ ID NO. 3, wherein the 206 th amino acid of the aflatoxin degradation enzyme mutant is changed from Ala into Phe.
The amino acid sequence of the mutant is SEQ ID NO. 5, and one coding nucleotide sequence of the mutant is SEQ ID NO. 6.
The invention also provides a polypeptide carrying the coding sequence of SEQ ID NO:4 or SEQ ID NO:6, and (3) a recombinant expression vector of the aflatoxin degradation enzyme mutant gene.
The invention also provides a pichia pastorisPichia pastoris) Comprising the above recombinant expression vector.
The plasmid is transferred into pichia pastoris, and the specific enzyme activity level of the recombinant expressed aflatoxin degradation enzyme mutant is obviously improved.
The pichia pastoris also comprises an acetyl coenzyme A synthetase C2 gene.
The coding nucleotide sequence of the acetyl coenzyme A synthetase C2 gene is SEQ ID NO: 7.
the acetyl coenzyme A synthetase C2 gene is transferred into pichia pastoris, and the enzyme activity level of the recombinant expressed aflatoxin degradation enzyme mutant is obviously improved.
The pichia is named as pichia Huang2-X2-43 (Pichia pastoris Huang 2-X2-43), which has been preserved in China center for type culture Collection of Wuhan university in Wuhan, China in 2020, 12, month 2, with the preservation number CCTCC NO: m2020820.
Compared with the wild type, the aflatoxin degrading enzyme mutants HUANG1-X1 and HUANG1-X2 provided by the invention are recombined and expressed in pichia pastoris, the specific enzyme activity is respectively improved by 97.2% and 108.5%, and unexpected technical effects are achieved.
In addition, the enzyme activity of the aflatoxin degradation enzyme mutant can be obviously improved by co-expressing the acetyl coenzyme A synthetase C2 gene in cells in pichia pastoris engineering bacteria. The highest fermentation enzyme activity of the modified Pichia pastoris Huang2-X2-43 reaches 331U/ml, which is improved by 63% compared with that before modification. The pichia pastoris strain can be widely applied to the production of aflatoxin degradation enzyme, and is beneficial to reducing the production cost of the enzyme, so that the wide application of the pichia pastoris strain in the field of feeds is promoted.
Detailed Description
The present invention uses conventional techniques and methods used IN the fields of genetic engineering and MOLECULAR BIOLOGY, such as the methods described IN MOLECULAR CLONING, A LABORATORY MANUAL, 3nd Ed. (Sambrook, 2001) and CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (Ausubel, 2003). These general references provide definitions and methods known to those skilled in the art. However, those skilled in the art can adopt other conventional methods, experimental schemes and reagents in the field on the basis of the technical scheme described in the invention, and the invention is not limited to the specific embodiment of the invention.
Strain and carrier: coli DH5 alpha deposited by the same company, Pichia pastoris GS115, vector pPIC9k, pPICZA, Amp, G418, Zeocin were purchased from Invitrogen.
Enzyme and kit: DNA polymerase was purchased from Takara, T4 ligase, restriction enzyme from Fermentas, plasmid extraction kit and gel purification recovery kit from Omega, GeneMorph II random mutagenesis kit from Beijing Bomais Biotech, Inc., and Aflatoxin degrading enzyme detection kit RIDASCREEN Aflatoxin B130/15R 1211 from R-Biopharm.
The formula of the culture medium is as follows:
coli medium (LB medium): 0.5% yeast extract, 1% peptone, 1% NaCl, ph 7.0;
LB + Amp medium: adding 100 mu g/mL ampicillin into LB culture medium;
yeast medium (YPD medium): 1% yeast extract, 2% peptone, 2% glucose;
YPD + Zeocin medium: adding 100 mu g/ml Zeocin into YPD culture medium;
yeast screening medium (MD medium): 1.34% YNB, 4X 10 -5 Biotin, 1% glycerol, 2% agarose;
BMGY medium: 2% peptone, 1% yeast extract, 100 mM potassium phosphate buffer (pH6.0), 1.34% YNB, 4X 10 -5 Biotin, 1% glycerol;
BMMY medium: 2% peptone, 1% yeast extract, 100 mM potassium phosphate buffer (pH6.0), 1.34% YNB, 4X 10 -5 Biotin, 0.5% methanol.
Example 1 Gene Synthesis of Aflatoxin-degrading enzyme HUANG2
The aflatoxin-degrading enzyme gene derived from Bacillus amyloliquefaciens (Bacillus amyloliquefaciens) is named HUANG2, the nucleotide sequence of which is SEQ ID NO. 2, and the coding amino acid sequence of which is SEQ ID NO. 1. The entire gene synthesis was carried out by Huada Gene Co.
Example 2 screening of Aflatoxin degrading enzyme HUANG2 mutant
In order to further improve the specific activity of the aflatoxin degradation enzyme HUANG2, a large number of mutations are screened for the gene of the aflatoxin degradation enzyme by a directed evolution technology. The aflatoxin-degrading enzyme HUANG2 was used as a template, and PCR amplification was carried out using GeneMorph II random mutation PCR kit (Stratagene) using primer 1(F) and primer 1 (R).
Primer 1 (F): GCGCGAATTCATGAAACTGGCCTTAGATCCATCCA;
Primer 1 (R): TAAAGCGGCCGCTTATGCCATGCCTAATTCTTCCTTT。
The PCR product is recovered by glue and then,EcoRI、Noti, after enzyme digestion treatment, connecting the vector with pET21a vector subjected to the same enzyme digestion, transforming the vector into escherichia coli BL21(DE3), coating the escherichia coli BL21 on an LB + Amp flat plate, and performing inverted culture at 37 ℃; after the transformants appear, the transformants are picked to a 96-well plate one by using toothpicks, 150 ul LB + Amp culture medium containing 0.1mM IPTG is added into each well, the culture is carried out for about 6 h at 37 ℃ and 220rpm, the supernatant is discarded by centrifugation, the thalli are resuspended by using buffer solution, and the walls are broken by repeated freeze thawing, so as to obtain the escherichia coli cell lysate containing the aflatoxin degradation enzyme. And then centrifuging to remove thalli, respectively measuring the activity and the protein content of the aflatoxin degradation enzyme of the supernatant, and calculating the specific enzyme activity.
The experimental result shows that some mutations have no influence on the specific enzyme activity of the aflatoxin degradation enzyme HUANG2, and some mutations even make the specific enzyme activity lower. Finally, the applicant screens and obtains mutation sites and combinations capable of obviously improving the specific enzyme activity of the aflatoxin degradation enzyme HUANG 2: R93V single point mutation, R93V/A206F two point mutation.
The aflatoxin degradation enzyme mutant containing R93V single-point mutation is named as HUANG2-X1, and the amino acid sequence of the mutant is SEQ ID NO:3, the nucleic acid sequence of one coding gene is SEQ ID NO: 4.
the aflatoxin degradation enzyme mutant containing two point mutations of R93V and A206F is named as HUANG2-X2, and the amino acid sequence of the mutant is SEQ ID NO:5, the nucleic acid sequence of one coding gene is SEQ ID NO: 6.
the above nucleotide sequences were synthesized by Huada Gene Co.
The two mutants were subjected to PCR amplification using primer 1(F) and primer 1(R) under the following conditions: denaturation at 94 deg.C for 5 min; then denaturation at 94 ℃ for 30s, renaturation at 56 ℃ for 30s, extension at 72 ℃ for 1min, and after 35 cycles, heat preservation at 72 ℃ for 10 min. The length of the mutant HUANG2-X1 and HUANG2-X2 genes is the same as that of the wild-type HUANG2 gene, and the total length is about 870 bp.
Example 3 construction of Pichia pastoris engineering bacteria expressing recombinant Aflatoxin degrading enzymes
1. Construction of recombinant plasmid
Respectively using restriction endonuclease to obtain aflatoxin degradation enzyme gene HUANG2 and mutant genes HUANG2-X1 and HUANG2-X2EcoR I andNoti, carrying out double digestion, wherein 100 mu l of digestion system is as follows: 40. mu.l of PCR product of aflatoxin-degrading enzyme gene HUANG2 (HUANG 2-X1, HUANG 2-X2), 10. mu.l of 10 XHbuffer, 10. mu.l of 10 XBA, etc,EcoR I 5 μl、Not I 5 μl、ddH 2 O30. mu.l. After digestion at 37 ℃ for 4 h, the product was recovered by agarose gel electrophoresis.
The expression vector pPIC9K was first treated with restriction enzymeEcoR I A single digestion was carried out, and 100. mu.l of the digestion system was as follows: 20. mu.l of expression vector pPIC9K 20, 10 XH buffer 10. mu.l,EcoR I 5 μl、ddH 2 O65. mu.l. After digestion at 37 ℃ for 4 h, the product was recovered by agarose gel electrophoresis. Reuse of the recovered fragments with restriction enzymesNotI, performing single enzyme digestion, wherein 100 mu l of enzyme digestion system is as follows: mu.l of the pPIC9K recovered fragment, 10. mu.l of 10 XH buffer, 10. mu.l of 10 XBSA 10. mu.l of 10 XTuton 10. mu.l,Not I 5 μl、ddH 2 And O45 mu.l. After digestion at 37 ℃ for 4 h, the product was recovered by agarose gel electrophoresis.
Will be passedEcoR I andNotthe double-restriction enzyme-digested HUANG2 fragment, HUANG2-X1 fragment and HUANG2-X2 fragment are respectively connected with an expression vector pPIC9K which is subjected to the same restriction enzyme digestion to construct recombinant expression plasmids pPIC9K-HUANG2, pPIC9K-HUANG2-X1 and pPIC9K-HUANG 2-X2. The linking system is as follows: expression vector pPIC9K double enzyme digestion product 5 ul, HUANG2 (HUANG 2-X1, HUANG 2-X2) gene double enzyme digestion product 3 ul, 10 XT 4 ligase buffer 1 μl、T 4 1 μ l of ligase. The ligation was carried out overnight at 22 ℃ and transformed into E.coli DH 5. alpha. and transformants were picked for sequencing verification. And (3) transferring the transformants which are verified to be correct by sequencing into an LB + Amp liquid culture medium, culturing overnight at 37 ℃, and upgrading the plasmids to obtain recombinant yeast expression plasmids pPIC9K-HUANG2 (pPIC 9K-HUANG2-X1, pPIC9K-HUANG 2-X2).
Transformation and screening
The recombinant yeast expression plasmids pPIC9K-HUANG2, pPIC9K-HUANG2-X1 and pPIC9K-HUANG2-X2 were used respectivelySalI, linearization, purifying a linearization product by using a column purification kit, converting pichia pastoris GS115 by an electroporation method, and coating an MD plate. The colony grown on the MD plate is the pichia pastoris engineering strain, and then YPD plates containing different concentrations of geneticin G418 are coated to screen multi-copy transformants.
Shake flask fermentation verification
Selecting single multi-copy transformants, respectively inoculating into BMGY culture medium, performing shake culture at 30 ℃ and 220rpm for 24 hours, then transferring into BMMY culture medium, performing shake culture at 30 ℃ and 220rpm, and adding 0.5% methanol every 24 hours. After the induction expression is carried out for 4 days, the thalli are removed by centrifugation, the activity of the aflatoxin degradation enzyme and the protein content of the supernatant are respectively measured, and the specific enzyme activity is calculated.
The result shows that the maximum fermentation enzyme activity of a transformant for recombinant expression of the wild aflatoxin degradation enzyme gene HUANG2 reaches 105U/ml, the protein content is 0.31g/l, and the specific enzyme activity is 338.7U/mg under the condition of a shake flask. The transformant was named Pichia pastoris HUANG2-21 (Pichia pastoris HUANG2-21);
The highest fermentation enzyme activity of a transformant for recombinantly expressing the aflatoxin degradation enzyme mutant gene HUANG2-X1 reaches 187U/ml, the protein content is 0.28g/l, and the specific enzyme activity is 667.9U/mg. The transformant was named Pichia pastoris HUANG2-X1-44 (Pichia pastoris HUANG2-X1-44);
The maximum fermentation enzyme activity of a transformant for recombinant expression of the aflatoxin degrading enzyme mutant gene HUANG2-X2 reaches 226U/ml, the protein content is 0.32g/l, and the specific enzyme activity is 706.3U/mg. The transformant was named Pichia pastoris HUANG2-X2-89 (Pichia pastoris HUANG2-X2-89);
From the results, compared with the wild type, the mutant genes HUANG1-X1 and HUANG1-X2 provided by the invention are recombined and expressed in pichia pastoris, so that the specific enzyme activities are respectively improved by 97.2% and 108.5%, and unexpected technical effects are achieved.
Aflatoxin degrading enzyme biopsy detection method
1. Definition of enzyme Activity Unit
The amount of enzyme required to degrade 1 pmol AFB1 per minute at pH6.0 and 30 ℃ was one enzyme activity unit (U/g or U/ml).
2. Sample processing method
Liquid sample: the supernatant was centrifuged and used directly for the subsequent assay.
3. Experimental procedure for enzyme reactions
TABLE 1 enzymatic reaction procedure
Figure 687466DEST_PATH_IMAGE001
In the enzyme reaction test operation, 45ml of buffer solution (0.02M citric acid-0.04M disodium hydrogen phosphate, pH6.0) and 2.5ml of AFB1 standard stock solution (2 ug/ml) are precisely taken and mixed uniformly (18: 1), and then 1.9ml is precisely measured to reduce the test deviation.
4. Enzyme activity calculation method
Figure DEST_PATH_IMAGE002
In the formula:
u is enzyme activity, U/ml;
f is the dilution multiple;
c, comparison: control AFB1 concentration, ppb;
c, test: test group AFB1 concentration, ppb;
v: sample volume, ml.
Detection of protein content by Coomassie brilliant blue method
1. Reagent
(1) Coomassie brilliant blue G-250 staining solution: dissolving Coomassie brilliant blue G-250100 mg in 50ml 95% ethanol, adding 100ml 85% phosphoric acid, diluting with water to 1L, and using at normal temperature for 1 month;
(2) standard protein solution: measuring the protein content by using bovine serum albumin through a trace Kjeldahl method in advance, and preparing a 1 mg/ml protein standard solution according to the purity of the protein;
(3) preparing a standard stock solution: accurately weighing 0.05g of crystallized bovine serum albumin on an analytical balance, adding a small amount of distilled water into a small beaker, dissolving, transferring into a 50ml volumetric flask, washing residual liquid in the beaker with a small amount of distilled water for several times, pouring the washing liquid into the volumetric flask together, and finally fixing the volume to the scale with the distilled water. A standard stock solution was prepared in which the concentration of bovine serum albumin was 1000. mu.g/ml.
2. And (5) drawing a standard curve.
(1) The 6 test tubes are respectively numbered, the reagents are added according to the following table, and the mixture is uniformly mixed.
Pipe number 1 2 3 4 5 6
Sample (ml) 0 0.1 0.2 0.3 0.4 0.5
Water (ml) 2.0 1.9 1.8 1.7 1.6 1.5
Protein content (mg/ml) 0 0.05 0.1 0.15 0.2 0.25
(2) Accurately sucking 2.5ml of Coomassie brilliant blue solution into 6 dry test tubes, accurately sucking 0.1ml of the solution in each tube, correspondingly placing the solution in each numbered test tube, uniformly mixing by vortex, standing at room temperature for 5min, zeroing with test tube No. 1, measuring at 595nm for color comparison, and recording the light absorption value.
(3) Drawing a standard curve: the absorbance values read by the 1-6 tubes were recorded, and a standard curve was drawn with the protein content (μ g) as the abscissa and the absorbance as the ordinate. Note that the cuvette had to be cleaned due to the strong staining ability of coomassie brilliant blue. Cannot be measured with a quartz cup.
3. Determination of samples
(1) Preparation of samples:
diluting a sample to be detected to the protein content of 0.1-0.3mg/ml, and controlling the light absorption value (after blank is subtracted) after blank is removed to be 0.2-0.4;
(2) sample detection:
adding a clean test tube into a Coomassie brilliant blue solution containing 2.5ml, adding a sample to be tested, vortexing, shaking uniformly, standing at room temperature for 5min, taking a blank of a standard curve as a control, measuring absorbance at 595nm by using a micro cuvette with an optical path of 1cm, and obtaining the protein content according to the standard curve.
4. Protein content calculation
Protein content = X dilution fold × standard conversion factor.
X: protein content (mg/ml) determined from the standard.
Reduced value of standard sample: the standard sample was 47mg/ml, and a coefficient was converted from the measured value.
(III) calculation of specific enzyme Activity
"Specific Activity" means: the number of units of enzyme activity per weight of protein is generally expressed as U/mg protein. In general, the higher the specific enzyme activity, the more pure the enzyme.
Specific activity calculation formula: specific enzyme activity (U/mg) = enzyme activity (U/mL)/protein content (mg/mL).
Example 4 modification of regulatory Gene of Pichia pastoris HUANG2-X2-89
1. Cloning of acetyl-CoA synthetase C2
Taking genome of Pichia pastoris GS115 as a template, cloning acetyl coenzyme A synthetase C2 gene by PCR reaction, wherein primers and reaction conditions are as follows:
primer 1 (F): GCGCGAATTCATGACTTTTCCAGAGCCAAGAGAACACAAA;
Primer 1 (R): TAAAGCGGCCGCCTACTTCTTGAAGAACTGGTTATCAACAG。
The PCR conditions were: denaturation at 94 deg.C for 5 min; then denaturation at 94 ℃ for 30s, renaturation at 56 ℃ for 30s, extension at 72 ℃ for 2min for 30s, and after 35 cycles, heat preservation at 72 ℃ for 10 min. The total length of the acetyl coenzyme A synthetase C2 gene is 2019bp, and the nucleotide sequence is SEQ ID NO: 7.
construction of expression plasmid for acetyl-CoA synthetase C2 Gene
Restriction enzyme for the cloned acetyl-CoA synthetase C2 GeneEcoR I andNoti, carrying out double digestion, wherein 50 mu l of digestion system is as follows: 43. mu.l of acetyl-CoA synthetase C2 gene, 5. mu.l of 10 XFastdigest Buffer,EcoR I 1 μl、NotI1. mu.l. After digestion at 37 ℃ for 2h, the product was recovered by agarose gel electrophoresis.
Restriction enzyme for expression vector pPICZAEcoR I andNoti, carrying out double digestion, wherein 50 ul of digestion system is as follows: the vector pPICZA 43. mu.l, 10 XFastdigest Buffer 5. mu.l,EcoR I 1 μl、NotI1. mu.l. After digestion at 37 ℃ for 2h, the product was recovered by agarose gel electrophoresis.
Will be passed throughEcoR I andNotthe I double enzyme-digested acetyl coenzyme A synthetase C2 gene fragment is connected with an expression vector pPICZA subjected to the same enzyme digestion to construct a recombinant expression plasmid pPICZA-C2. The linking system is as follows: 5 mul of expression vector pPICZA double restriction enzyme products, 3 mul of acetyl coenzyme A synthetase C2 gene double restriction enzyme products and 10 XT 4 ligase buffer 1 μl、T 4 1 μ l of ligase. The ligation was carried out overnight at 22 ℃ and transformed into E.coli DH 5. alpha. and transformants were picked for sequencing verification. And (3) transferring the transformant which is verified to be correct by sequencing into an LC + Zeocin liquid medium, carrying out overnight culture at 37 ℃, and upgrading the plasmid to obtain the yeast intracellular expression plasmid pPICZA-C2.
The regulatory gene C2 is transferred into pichia pastoris HUANG2-X2-89
The recombinant plasmid pPICZA-C2 was treated with restriction enzymesSacI linearization, purification of linearization product with column purification kit, transformation of Pichia pastoris HUANG2-X2-89 by electroporation, and coating YPD + Zeocin plate. Growing on YPD + Zeocin plateThe bacterial colony is the pichia pastoris engineering strain transformed into C2.
Strain shake flask fermentation screening verification
A plurality of positive transformants were picked and inoculated into BMGY medium respectively, after shaking culture at 30 ℃ and 220rpm for 24 hours, transferred into BMMY medium, and shaking culture at 30 ℃ and 220rpm was carried out, using HUANG2-X2-89 strain as a control, and 0.5% methanol was added every 24 hours. After the induction expression is carried out for 4 days, the thalli are removed by centrifugation, and the activity of the aflatoxin degradation enzyme is measured on the supernatant.
The result shows that the fermentation enzyme activity of the Pichia pastoris HUANG2-X2-89 before modification is 203U/ml under the condition of a shake flask; the highest fermentation enzyme activity in the transformant transferred into the C2 gene reaches 331U/ml, and the transformant is named as pichia pastoris Huang2-X2-43 (C2)Pichia pastoris Huang 2-X2-43). Therefore, the intracellular co-expression of the C2 gene in the pichia pastoris engineering bacteria can obviously improve the enzyme activity of the aflatoxin degradation enzyme mutant HUANG2-X2, the improvement proportion reaches 63 percent, and unexpected technical effects are achieved.
The applicant has already applied Pichia pastoris Huang2-X2-43 (at 12/2/2020;)Pichia pastoris Huang 2-X2-43) is preserved in China center for type culture Collection of Wuhan university in Wuhan, China, with the preservation number of CCTCC NO: m2020820.
Sequence listing
<110> Weifang kang Den Biotech Co., Ltd
QINGDAO VLAND BIOTECH GROUP Co.,Ltd.
<120> aflatoxin degrading enzyme mutant and high-yield strain thereof
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 289
<212> PRT
<213> Bacillus amyloliquefaciens (Bacillus amyloliquefaciens)
<400> 1
Met Lys Leu Ala Leu Asp Pro Ser Met Tyr Arg Asp Asp Leu Thr Leu
1 5 10 15
Glu Glu Met Val Tyr Lys Thr Ala Glu Leu Gly Tyr Glu Tyr Ile Glu
20 25 30
Leu Ser Pro Arg Glu Asp Phe Cys Pro Phe Tyr Lys Tyr Pro Lys Val
35 40 45
Asp Ser Ala Lys Ile Lys Gln Leu Lys Arg Leu Leu Lys Asp Thr Gly
50 55 60
Val Lys Leu Ser Ser Leu Leu Pro Leu Tyr His Trp Ala Gly Pro Asp
65 70 75 80
Glu Asp Arg Arg Gln Ala Ala Val Arg Asn Trp Lys Arg Ala Ile Glu
85 90 95
Ile Ala Val Glu Leu Glu Val Asp Leu Met Asn Ser Glu Phe Ser Gly
100 105 110
Ser Lys Tyr Asp Pro Leu Thr Ser Glu Glu Lys Phe Ile Lys Ser Met
115 120 125
Asp Glu Leu Leu Pro Val Phe Glu Lys Glu Gly Val Lys Leu Asn Leu
130 135 140
Gln Ala His Pro Tyr Asp Phe Ile Glu Thr His Lys Gly Ala Met Asp
145 150 155 160
Met Ile Arg Ala Leu Asp Lys Asp Trp Ile Asn Leu Val Tyr Ser Thr
165 170 175
Ala His Thr Phe Phe Tyr Asp Asp Gly Lys Gly Asp Ile Ala Thr Met
180 185 190
Phe Asp Glu Ala Gly Asp Arg Leu Thr His Val Leu Phe Ala Asp Thr
195 200 205
Phe Asn His Lys Ala Ala His Gly Leu Arg Tyr Ile Val Asn Pro Pro
210 215 220
Asp Ala Lys Val Thr Val His Gln His Leu Asp Ile Gly Gln Gly Glu
225 230 235 240
Val Asp Phe Glu Thr Ile Phe Arg Lys Met Arg Glu Met Lys Phe Asp
245 250 255
Gly Ile Ala Thr Asn Ala Val Phe Ala Trp Val Gly Glu Arg Ala Asp
260 265 270
Glu Ser Ser Arg Thr Thr Leu Lys Lys Leu Lys Glu Glu Leu Gly Met
275 280 285
Ala
<210> 2
<211> 870
<212> DNA
<213> Bacillus amyloliquefaciens (Bacillus amyloliquefaciens)
<400> 2
atgaaactgg ccttagatcc atccatgtac cgtgatgatt taacgttaga ggaaatggtc 60
tataaaacgg cggagctcgg atatgaatat atcgaattgt ccccgcgcga ggatttttgt 120
cctttctaca aatatccgaa agtcgattca gcaaaaatca aacaattgaa gcgcctttta 180
aaggatacag gtgtgaagct gtcctctctt cttccgcttt accactgggc gggtcctgat 240
gaagaccgcc gacaggccgc cgtgcgcaac tggaaacggg cgatcgaaat tgcggttgaa 300
cttgaagtgg atttgatgaa cagtgaattc agcggttcaa aatatgatcc tttgacaagt 360
gaagaaaaat ttatcaaatc catggatgaa ctgctgcccg tttttgaaaa agaaggcgtt 420
aaactcaatc ttcaggctca cccatacgat tttatcgaaa cgcacaaagg cgcgatggat 480
atgatccgcg cgcttgacaa ggattggatc aatcttgtct actcgactgc gcatacgttc 540
ttctatgatg acggaaaagg cgatattgcg accatgtttg atgaagccgg cgaccgcctt 600
acacatgttt tatttgcaga tacttttaat cataaagcgg cgcacggcct gcgttacatc 660
gtcaacccgc ctgatgcgaa agtaacggtt caccagcatt tggacatcgg tcaaggcgag 720
gttgattttg agacgatttt cagaaagatg agagagatga aattcgacgg aattgcgacg 780
aacgccgttt ttgcttgggt cggcgaaaga gcggatgaat caagccggac cacgcttaag 840
aaattaaagg aagaattagg catggcataa 870
<210> 3
<211> 289
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 3
Met Lys Leu Ala Leu Asp Pro Ser Met Tyr Arg Asp Asp Leu Thr Leu
1 5 10 15
Glu Glu Met Val Tyr Lys Thr Ala Glu Leu Gly Tyr Glu Tyr Ile Glu
20 25 30
Leu Ser Pro Arg Glu Asp Phe Cys Pro Phe Tyr Lys Tyr Pro Lys Val
35 40 45
Asp Ser Ala Lys Ile Lys Gln Leu Lys Arg Leu Leu Lys Asp Thr Gly
50 55 60
Val Lys Leu Ser Ser Leu Leu Pro Leu Tyr His Trp Ala Gly Pro Asp
65 70 75 80
Glu Asp Arg Arg Gln Ala Ala Val Arg Asn Trp Lys Val Ala Ile Glu
85 90 95
Ile Ala Val Glu Leu Glu Val Asp Leu Met Asn Ser Glu Phe Ser Gly
100 105 110
Ser Lys Tyr Asp Pro Leu Thr Ser Glu Glu Lys Phe Ile Lys Ser Met
115 120 125
Asp Glu Leu Leu Pro Val Phe Glu Lys Glu Gly Val Lys Leu Asn Leu
130 135 140
Gln Ala His Pro Tyr Asp Phe Ile Glu Thr His Lys Gly Ala Met Asp
145 150 155 160
Met Ile Arg Ala Leu Asp Lys Asp Trp Ile Asn Leu Val Tyr Ser Thr
165 170 175
Ala His Thr Phe Phe Tyr Asp Asp Gly Lys Gly Asp Ile Ala Thr Met
180 185 190
Phe Asp Glu Ala Gly Asp Arg Leu Thr His Val Leu Phe Ala Asp Thr
195 200 205
Phe Asn His Lys Ala Ala His Gly Leu Arg Tyr Ile Val Asn Pro Pro
210 215 220
Asp Ala Lys Val Thr Val His Gln His Leu Asp Ile Gly Gln Gly Glu
225 230 235 240
Val Asp Phe Glu Thr Ile Phe Arg Lys Met Arg Glu Met Lys Phe Asp
245 250 255
Gly Ile Ala Thr Asn Ala Val Phe Ala Trp Val Gly Glu Arg Ala Asp
260 265 270
Glu Ser Ser Arg Thr Thr Leu Lys Lys Leu Lys Glu Glu Leu Gly Met
275 280 285
Ala
<210> 4
<211> 870
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atgaaactgg ccttagatcc atccatgtac cgtgatgatt taacgttaga ggaaatggtc 60
tataaaacgg cggagctcgg atatgaatat atcgaattgt ccccgcgcga ggatttttgt 120
cctttctaca aatatccgaa agtcgattca gcaaaaatca aacaattgaa gcgcctttta 180
aaggatacag gtgtgaagct gtcctctctt cttccgcttt accactgggc gggtcctgat 240
gaagaccgcc gacaggccgc cgtgcgcaac tggaaagttg cgatcgaaat tgcggttgaa 300
cttgaagtgg atttgatgaa cagtgaattc agcggttcaa aatatgatcc tttgacaagt 360
gaagaaaaat ttatcaaatc catggatgaa ctgctgcccg tttttgaaaa agaaggcgtt 420
aaactcaatc ttcaggctca cccatacgat tttatcgaaa cgcacaaagg cgcgatggat 480
atgatccgcg cgcttgacaa ggattggatc aatcttgtct actcgactgc gcatacgttc 540
ttctatgatg acggaaaagg cgatattgcg accatgtttg atgaagccgg cgaccgcctt 600
acacatgttt tatttgcaga tacttttaat cataaagcgg cgcacggcct gcgttacatc 660
gtcaacccgc ctgatgcgaa agtaacggtt caccagcatt tggacatcgg tcaaggcgag 720
gttgattttg agacgatttt cagaaagatg agagagatga aattcgacgg aattgcgacg 780
aacgccgttt ttgcttgggt cggcgaaaga gcggatgaat caagccggac cacgcttaag 840
aaattaaagg aagaattagg catggcataa 870
<210> 5
<211> 289
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 5
Met Lys Leu Ala Leu Asp Pro Ser Met Tyr Arg Asp Asp Leu Thr Leu
1 5 10 15
Glu Glu Met Val Tyr Lys Thr Ala Glu Leu Gly Tyr Glu Tyr Ile Glu
20 25 30
Leu Ser Pro Arg Glu Asp Phe Cys Pro Phe Tyr Lys Tyr Pro Lys Val
35 40 45
Asp Ser Ala Lys Ile Lys Gln Leu Lys Arg Leu Leu Lys Asp Thr Gly
50 55 60
Val Lys Leu Ser Ser Leu Leu Pro Leu Tyr His Trp Ala Gly Pro Asp
65 70 75 80
Glu Asp Arg Arg Gln Ala Ala Val Arg Asn Trp Lys Val Ala Ile Glu
85 90 95
Ile Ala Val Glu Leu Glu Val Asp Leu Met Asn Ser Glu Phe Ser Gly
100 105 110
Ser Lys Tyr Asp Pro Leu Thr Ser Glu Glu Lys Phe Ile Lys Ser Met
115 120 125
Asp Glu Leu Leu Pro Val Phe Glu Lys Glu Gly Val Lys Leu Asn Leu
130 135 140
Gln Ala His Pro Tyr Asp Phe Ile Glu Thr His Lys Gly Ala Met Asp
145 150 155 160
Met Ile Arg Ala Leu Asp Lys Asp Trp Ile Asn Leu Val Tyr Ser Thr
165 170 175
Ala His Thr Phe Phe Tyr Asp Asp Gly Lys Gly Asp Ile Ala Thr Met
180 185 190
Phe Asp Glu Ala Gly Asp Arg Leu Thr His Val Leu Phe Phe Asp Thr
195 200 205
Phe Asn His Lys Ala Ala His Gly Leu Arg Tyr Ile Val Asn Pro Pro
210 215 220
Asp Ala Lys Val Thr Val His Gln His Leu Asp Ile Gly Gln Gly Glu
225 230 235 240
Val Asp Phe Glu Thr Ile Phe Arg Lys Met Arg Glu Met Lys Phe Asp
245 250 255
Gly Ile Ala Thr Asn Ala Val Phe Ala Trp Val Gly Glu Arg Ala Asp
260 265 270
Glu Ser Ser Arg Thr Thr Leu Lys Lys Leu Lys Glu Glu Leu Gly Met
275 280 285
Ala
<210> 6
<211> 870
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
atgaaactgg ccttagatcc atccatgtac cgtgatgatt taacgttaga ggaaatggtc 60
tataaaacgg cggagctcgg atatgaatat atcgaattgt ccccgcgcga ggatttttgt 120
cctttctaca aatatccgaa agtcgattca gcaaaaatca aacaattgaa gcgcctttta 180
aaggatacag gtgtgaagct gtcctctctt cttccgcttt accactgggc gggtcctgat 240
gaagaccgcc gacaggccgc cgtgcgcaac tggaaagttg cgatcgaaat tgcggttgaa 300
cttgaagtgg atttgatgaa cagtgaattc agcggttcaa aatatgatcc tttgacaagt 360
gaagaaaaat ttatcaaatc catggatgaa ctgctgcccg tttttgaaaa agaaggcgtt 420
aaactcaatc ttcaggctca cccatacgat tttatcgaaa cgcacaaagg cgcgatggat 480
atgatccgcg cgcttgacaa ggattggatc aatcttgtct actcgactgc gcatacgttc 540
ttctatgatg acggaaaagg cgatattgcg accatgtttg atgaagccgg cgaccgcctt 600
acacatgttt tattttttga tacttttaat cataaagcgg cgcacggcct gcgttacatc 660
gtcaacccgc ctgatgcgaa agtaacggtt caccagcatt tggacatcgg tcaaggcgag 720
gttgattttg agacgatttt cagaaagatg agagagatga aattcgacgg aattgcgacg 780
aacgccgttt ttgcttgggt cggcgaaaga gcggatgaat caagccggac cacgcttaag 840
aaattaaagg aagaattagg catggcataa 870
<210> 7
<211> 2019
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
atgacttttc cagagccaag agaacacaaa gtggtgcacg aagccaacgg cgtaagggct 60
atcaaaaccc ctcaatcatt ttatgacaag caacctgtta agtcattgga ggcattggaa 120
cattatcaag agctgtacca gaagtccatc gaggacccag aggaattctt cggccaaatg 180
gcaaagcagt ttctagattg ggacaaagac tttggtaagg tctcctctgg atctttgaaa 240
gaaggtgatg ctgcgtggtt ccttggtgga gagctgaatg cttcgtacaa ctgtgttgac 300
cgacatgctt tttcgcaccc tgatcgtccc gccgtaattt tcgaagcgga cgaggaatct 360
gaatctcgaa caataactta tgcagaactt ctacgtgagg tctctcgtgt tgcaggagta 420
ctgcagagct ggggtgtacg caaaggtgac actgtcgcaa tctacttgcc catgactacc 480
gaggccattg tggccatgct ggcagtggca cgtctgggtg cagtgcactc cgttatcttt 540
tctggatttt cgtcaggatc tatccgggac agagttaacg atgctggatc taaggcaatt 600
attacctgtg atgagggacg ccgtgggggt cgtattgtga acaataagaa aattgtcgat 660
gccgctgttg acagctgccc cacagtggaa aaaatcctgg tttataagag gactggtaac 720
ccagaaatca agatggtaga aggaagagac ttctggtggc aggaagaggt tgagaaattc 780
cctggttaca ttgcccctgt ccctgtaaac tcggaggacc cactatttct tttgtatact 840
tcgggatcta ctggttctcc caaaggtgtg gtacactcca caggtggtta tttgctggga 900
gcagcattga caactcgtta tgtgtttgat gtccaggatg aggatattat atttactgct 960
ggtgacgtcg gatggattac tggtcacaca tactcgttgt atggaccact tgttctgggt 1020
gttccaacca ttgtttttga gggaactcct gtctaccctg actacggaag attgtggaag 1080
atttgcgcca aacataaagc cacacacttt tacatcgctc ctactgctct tcgtcttttg 1140
aaaaaggctg gtgaagaaga aattaaaaag tacgacttgt ctagacttcg tactttagga 1200
tctgttggtg aaccaattgc ccccgaattg tgggagtggt acaatgagaa aatcggaaac 1260
ggaaactgtc atattgctga tacttactgg cagactgaat ctggttctca tttgattgct 1320
ccattagcag gtgccgttcc ccaaaagccg ggtgcagcta ctgttccttt ctttggtatt 1380
gatgcttgta tcattgaccc tgtttctggt aaggaacttg aaggcaacga tgtggaaggt 1440
gttttagctg tcaagtccac ttggccatca atggctcgta cagtctggag aaaccacgct 1500
aaatacctcg acacatatat gcgtccttat ccaggctact actttactgg cgatggtgcc 1560
ggtagagatc acgatggtta ttactggatc cgtggtcgtg ttgacgatgt tgtcaatgta 1620
tctggccacc gtttatccac ttctgaaatt gaaagtgctt tactggaaaa tggcaaagtt 1680
gctgaagctg ctgtgattgg tatttccgat gagctaactg gtcaagctgt tattgctttt 1740
gtcgccttga aagatgccac tgactctgag aatttagacg ctctcagacg tgccttagtc 1800
ttgcatgttc gtggagaaat tggtccattt gcagctccta agtccgtgat tgtggttgat 1860
gacttgccta agacccgatc aggtaagatc atgcgtagag ttttaagaaa gatttcttgc 1920
catgaagctg atcaattggg tgatatgtct actttggcca atcctgaatc ggtagactct 1980
ataatcggag ctgttgataa ccagttcttc aagaagtag 2019

Claims (7)

1. The aflatoxin degrading enzyme mutant is characterized in that the 93 rd amino acid of the aflatoxin degrading enzyme with an amino acid sequence of SEQ ID NO. 1 is changed from Arg to Val.
2. An aflatoxin-degrading enzyme mutant characterized in that the amino acid at position 206 of the aflatoxin-degrading enzyme mutant of claim 1 is changed from Ala to Phe.
3. A recombinant expression vector carrying a nucleic acid sequence having the coding sequence of SEQ ID NO:4 or SEQ ID NO:6 of the mutant gene of the aflatoxin degradation enzyme.
4. A kind of Pichia yeast (Pichia pastoris) Wherein the Pichia pastoris comprises the recombinant expression vector of claim 3.
5. The Pichia pastoris of claim 4, further comprising an acetyl-CoA synthetase C2 gene.
6. The pichia pastoris of claim 5, wherein the coding nucleotide sequence of the acetyl-coa synthetase C2 gene is SEQ ID NO: 7.
7. the pichia pastoris of claim 6, wherein the pichia pastoris has a accession number of CCTCC NO: m2020820.
CN202110124615.5A 2021-01-29 2021-01-29 Aflatoxin degrading enzyme mutant and high-yield strain thereof Active CN112725294B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110124615.5A CN112725294B (en) 2021-01-29 2021-01-29 Aflatoxin degrading enzyme mutant and high-yield strain thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110124615.5A CN112725294B (en) 2021-01-29 2021-01-29 Aflatoxin degrading enzyme mutant and high-yield strain thereof

Publications (2)

Publication Number Publication Date
CN112725294A CN112725294A (en) 2021-04-30
CN112725294B true CN112725294B (en) 2022-08-30

Family

ID=75594696

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110124615.5A Active CN112725294B (en) 2021-01-29 2021-01-29 Aflatoxin degrading enzyme mutant and high-yield strain thereof

Country Status (1)

Country Link
CN (1) CN112725294B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114807063B (en) * 2022-06-06 2024-05-07 江西省科学院生物资源研究所 Aflatoxin hydrolase, encoding gene thereof, recombinant vector, recombinant bacterium and application
CN114807074B (en) * 2022-06-06 2023-10-13 江西省科学院生物资源研究所 Aflatoxin hydrolase, encoding gene thereof, recombinant vector, recombinant bacterium and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109934A2 (en) * 2007-03-09 2008-09-18 Commonwealth Scientific And Industrial Research Organisation Degradation of coumarin based compounds
CN103555745A (en) * 2013-11-19 2014-02-05 华中师范大学 Gene for coding aflatoxin degradation enzyme and method for obtaining high-efficiency aflatoxin degradation enzyme
CN107760655B (en) * 2016-08-22 2021-02-26 中国农业大学 Aflatoxin degrading enzyme secreted by bacillus subtilis and application thereof

Also Published As

Publication number Publication date
CN112725294A (en) 2021-04-30

Similar Documents

Publication Publication Date Title
US20220025384A1 (en) Phytase mutants
CN112725294B (en) Aflatoxin degrading enzyme mutant and high-yield strain thereof
CN112760300B (en) Aflatoxin degrading enzyme mutant and production strain thereof
CN112760307B (en) Zearalenone toxin degrading enzyme mutant and production strain thereof
US7709240B2 (en) AMP deaminase originating streptomyces and utilization thereof
CN111893125A (en) Chitosan enzyme gene, chitosanase, preparation method and application thereof
CN112760299A (en) Glucose oxidase mutant with improved thermal stability as well as coding gene and application thereof
CN107384899B (en) Fungus-derived acidic protease g412 and gene and application thereof
CN113862233A (en) Method for improving acid stability of glucose oxidase, mutant Q241E/R499E, gene and application
CN108118037A (en) The glucose oxidase mutant that a kind of heat resistance improves
CN109371004B (en) Acid protease Bs2688 mutant K203E with improved thermal stability and gene and application thereof
CN114395540B (en) Application of aspergillus coronary glucose oxidase in improving flour processing quality
CN1578839A (en) Modulating urea degradation in wine yeast
CN107988190B (en) Acid protease and coding gene and application thereof
CN111394336A (en) Zearalenone hydrolase as well as coding gene and application thereof
CN109423483B (en) Glucose oxidase mutant
CN108795891B (en) Glucose oxidase CnGODA as well as gene and application thereof
CN108102934B (en) Aspergillus niger strain capable of producing pectin lyase at high yield
JP7071265B2 (en) Nuclesidase
CN112266923B (en) Bacillus subtilis for expressing adenomethionine synthase and application thereof
CN112877306B (en) Super-heat-resistant glucose oxidase AtGOD and gene and application thereof
CN112708604B (en) Zearalenone toxin degrading enzyme mutant and high-yield strain thereof
CN114395544A (en) High specific activity phytase mutant
CN109161489B (en) Aspergillus niger strain with high yield of acid protease
CN114736881A (en) Glucose oxidase GoxM10 mutant A4D with improved acid stability and derivative mutant and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant